Cargando…

The molecular mechanism of osteoclastogenesis: ODF/RANKL-dependent and independent pathways

Detalles Bibliográficos
Autores principales:	Suda, T, Takahashi, N, Udagawa, N, Miyaura, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273194/ http://dx.doi.org/10.1186/ar168

Ejemplares similares

Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
por: Kobayashi, Kanichiro, et al.
Publicado: (2000)

The molecular mechanism of osteoclastogenesis in rheumatoid arthritis
por: Udagawa, Nobuyuki, et al.
Publicado: (2002)

Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and –independent autophagic responses
por: Zhang, Guoyou, et al.
Publicado: (2019)

Pasteurella multocida Toxin Triggers RANKL-Independent Osteoclastogenesis
por: Chakraborty, Sushmita, et al.
Publicado: (2017)

Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL
por: Jang, Yuria, et al.
Publicado: (2021)

RANKL-independent osteoclastogenesis in the SH3BP2 cherubism mice
por: Kittaka, Mizuho, et al.
Publicado: (2020)

Mitf Induction by RANKL Is Critical for Osteoclastogenesis
por: Lu, Ssu-Yi, et al.
Publicado: (2010)

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
por: AlQranei, Mohammed S., et al.
Publicado: (2021)

A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro
por: Murakami, Kohei, et al.
Publicado: (2017)

RANKL Signaling and Osteoclastogenesis Is Negatively Regulated by Cardamonin
por: Sung, Bokyung, et al.
Publicado: (2013)

CD44 regulates bone erosion and osteoclastogenesis in arthritis
por: Hayer, S, et al.
Publicado: (2004)

RANKL-induced DC-STAMP Is Essential for Osteoclastogenesis
por: Kukita, Toshio, et al.
Publicado: (2004)

TRPM7 Is Essential for RANKL-Induced Osteoclastogenesis
por: Yang, Yu-Mi, et al.
Publicado: (2013)

The infrared A gene response of human dermal fibroblasts involves several mitochondria dependent and independent signaling pathways
por: Calles, C, et al.
Publicado: (2009)

Hippuric acid and 3‐(3‐hydroxyphenyl) propionic acid inhibit murine osteoclastogenesis through RANKL‐RANK independent pathway
por: Zhao, Haijun, et al.
Publicado: (2019)

The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis
por: Padovano, Costanzo, et al.
Publicado: (2023)

Isolated and combined inhibition of TNF-, IL-1 and RANKL-pathways in TNF-induced arthritis: effects on synovial inflammation, bone erosion and cartilage destruction
por: Zwerina, J, et al.
Publicado: (2003)

OPG and RANKL in serum and synovial fluids of patients with rheumatoid arthritis, osteoarthritis and spondylarthropathy
por: Krystufkova, O, et al.
Publicado: (2003)

Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis
por: Erkhembaatar, Munkhsoyol, et al.
Publicado: (2015)

Odf2 haploinsufficiency causes a new type of decapitated and decaudated spermatozoa, Odf2-DDS, in mice
por: Ito, Chizuru, et al.
Publicado: (2019)

The Molecular Mechanisms Study of Engeletin Suppresses RANKL-Induced Osteoclastogenesis and Inhibits Ovariectomized Murine Model Bone Loss
por: Feng, Mingzhe, et al.
Publicado: (2023)

Kynurenine Promotes RANKL-Induced Osteoclastogenesis In Vitro by Activating the Aryl Hydrocarbon Receptor Pathway
por: Eisa, Nada H., et al.
Publicado: (2020)

The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat
por: Ashtar, Mohannad, et al.
Publicado: (2020)

Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis
por: Ohshiba, T, et al.
Publicado: (2003)

Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis
por: Ozaki, Yuki, et al.
Publicado: (2017)

Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1
por: Song, Min-Kyoung, et al.
Publicado: (2015)

Follicle-Stimulating Hormone Does Not Impact RANKL-Induced Osteoclastogenesis
por: Zhou, Ziyue, et al.
Publicado: (2021)

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
por: Li, Jiarui, et al.
Publicado: (2022)

Icaritin ameliorates RANKL-mediated osteoclastogenesis and ovariectomy-induced osteoporosis
por: Huang, Jun-ming, et al.
Publicado: (2023)

Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL
por: Xing, Rui, et al.
Publicado: (2016)

RANK and RANKL expression in rheumatoid arthritis synovium and lymph nodes as markers of dendritic cell – T cell interactions
por: Page, G, et al.
Publicado: (2004)

IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis
por: Liang, Mengmeng, et al.
Publicado: (2019)

TNF-α and RANKL promote osteoclastogenesis by upregulating RANK via the NF-κB pathway
por: Luo, Gang, et al.
Publicado: (2018)

CCDC42 Localizes to Manchette, HTCA and Tail and Interacts With ODF1 and ODF2 in the Formation of the Male Germ Cell Cytoskeleton
por: Tapia Contreras, Constanza, et al.
Publicado: (2019)

Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
por: Kim, Jeong Yeon, et al.
Publicado: (2012)

Activation of G Proteins by Aluminum Fluoride Enhances RANKL-Mediated Osteoclastogenesis
por: Park, Boryung, et al.
Publicado: (2013)

Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts
por: Lee, Do-Won, et al.
Publicado: (2018)

Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis
por: Lombardi, Maria Stella, et al.
Publicado: (2017)

(−)-Epigallocatechin-3-Gallate Decreases Osteoclastogenesis via Modulation of RANKL and Osteoprotegrin
por: Chen, Shih-Tse, et al.
Publicado: (2019)

Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
por: Jiao, Yurui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nv672d8g4gv8h770qs5vo1k7t6